Botulinum Toxin Type A Targets RhoB to Inhibit Lysophosphatidic Acid-Stimulated Actin Reorganization and Acetylcholine Release in Nerve Growth Factor-Treated PC 12 Cells

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Scinderin, a Ca2+-Dependent Actin Filament Severing Protein that Controls Cortical Actin Network Dynamics During Secretion

  2004influential reference
• Inhalational Poisoning by Botulinum Toxin and Inhalation Vaccination with Its Heavy-Chain Component

  2003cited by this paper
• Mutational Analysis of the Enzymatic Domain of Clostridium difficile Toxin B Reveals Novel Inhibitors of the Wild-Type Toxin

  2003cited by this paper
• Rho GTPases in transformation and metastasis.

  2002cited by this paper
• Multiple forms of SNARE complexes in exocytosis from chromaffin cells: effects of Ca(2+), MgATP and botulinum toxin type A.

  2002cited by this paper
• Ca(2+) influx and cAMP elevation overcame botulinum toxin A but not tetanus toxin inhibition of insulin exocytosis.

  2001influential reference
• Farnesyltransferase inhibitors: mechanism and applications

  2001cited by this paper
• Ubiquitin-mediated degradation of cellular proteins: why destruction is essential for construction, and how it got from the test tube to the patient's bed.

  2001cited by this paper
• Actin' up: RhoB in cancer and apoptosis

  2001cited by this paper
• Farnesyltransferase and geranylgeranyltransferase I inhibitors in cancer therapy: important mechanistic and bench to bedside issues

  2000cited by this paper
• A Rho-related GTPase Is Involved in Ca2+-dependent Neurotransmitter Exocytosis*

  2000cited by this paper
• Proteasome inhibitors: a novel class of potent and effective antitumor agents.

  1999cited by this paper
• Bioactive lysophospholipids and their G protein-coupled receptors.

  1999influential reference
• Persistence of botulinum neurotoxin action in cultured spinal cord cells 1,2

  1999cited by this paper
• Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase.

  1999cited by this paper
• Characterization of Mayven, a novel actin-binding protein predominantly expressed in brain.

  1999cited by this paper
• RhoB Is Stabilized by Transforming Growth Factor β and Antagonizes Transcriptional Activation*

  1998cited by this paper
• The G-protein G13 but Not G12 Mediates Signaling from Lysophosphatidic Acid Receptor via Epidermal Growth Factor Receptor to Rho*

  1998cited by this paper
• Rho GTPases and signaling networks.

  1997cited by this paper
• The ubiquitin-mediated proteolytic pathway as a therapeutic area

  1997cited by this paper
• Acetylcholine exocytosis in PC12 cells deficient in SNAP‐25

  1997cited by this paper
• Involvement of Rho and Rac small G proteins and Rho GDI in Ca2+‐dependent exocytosis from PC12 cells

  1996influential reference
• Sphingosine‐1‐phosphate rapidly induces Rho‐dependent neurite retraction: action through a specific cell surface receptor.

  1996cited by this paper
• Rho guanine nucleotide dissociation inhibitor protein (RhoGDI) inhibits exocytosis in mast cells.

  1996cited by this paper
• Transient expression of RhoA, -B, and -C GTPases in HeLa cells potentiates resistance to Clostridium difficile toxins A and B but not to Clostridium sordellii lethal toxin

  1995cited by this paper
• Botulinum toxin inhibits arachidonic acid release associated with acetylcholine release from PC12 cells.

  1993cited by this paper
• Purification and characterization of a Z-Leu-Leu-Leu-MCA degrading protease expected to regulate neurite formation: a novel catalytic activity in proteasome.

  1993cited by this paper
• Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25

  1993influential reference
• Neurotransmitter release from lysophosphatidic acid stimulated PC12 cells: involvement of lysophosphatidic acid receptors.

  1993cited by this paper
• Small GTP-binding proteins.

  1992cited by this paper

• Therapeutic use of botulinum toxin in pain treatment

  2018cites this paper
• The Botulinum Toxin as a Therapeutic Agent: Molecular Structure and Mechanism of Action in Motor and Sensory Systems

  2016cites this paper
• Neuritogenic Actions of Botulinum Neurotoxin A on Cultured Motor Neurons

  2009cites this paper
• Mechanisms of action of intravesical botulinum treatment in refractory detrusor overactivity

  2008cites this paper
• Rho deep in thought.

  2007cites this paper
• Implication des voies de signalisation de l'adhérence cellulaire dans le contrôle de l'hypoxie tumorale des glioblastomes

  2007cites this paper
• Rho is a presynaptic activator of neurotransmitter release at pre-existing synapses in C. elegans.

  2006cites this paper